NORD: The Voice of the Community - May 2018


NORD's Voice of the Community - May 2018

Save The Date for the NORD Summit!

Mark your calendar for the NORD Rare Diseases and Orphan Products Breakthrough Summit, to take place on October 15-16 at the Marriott Wardman Park Hotel in Washington DC. This year’s theme will be “A New Era of Patient-Focused Innovation." The annual NORD Summit brings together thought leaders from across the spectrum of the rare disease community to address issues and opportunities of shared interest. Watch for upcoming news about the program, speakers, scholarships and more!

On NORD’s 35th Anniversary: A Reminder of Why NORD & the ODA Were Needed

This year marks the 35th anniversary of NORD and the Orphan Drug Act. (The history of the two is linked.) Read a blog about how it all began and why NORD and the Orphan Drug Act were needed. Also, here are 35 ways that NORD serves the rare disease community.

Rare Action Network™ Releases 2018 State Report Card

NORD’s Rare Action Network™ has grown to become the nation’s largest rare disease advocacy network, spanning all 50 states and including more than 4,000 dedicated advocates who stand ready to mobilize on issues affecting the rare disease community. The RAN “State Report Card” rates states on the strength of policies of importance to the rare disease community, such as newborn screening, prescription drug access and the establishment of rare disease advisory councils. Read the recently released 2018 State Report Card.

NORD Issues Response to Administration’s American Patients First

In response to the recently announced Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs, NORD released a statement, which can be read here.


NORD Welcomes New Member Organizations

NORD welcomes the following organizations to its community of members:

PTEN Hamartoma Tumor Foundation:

The Ehlers-Danlos Society:

Parents of Infants and Children with Kernicterus:

Neuroendocrine Tumor Research Foundation Announces New Round of Funding

The NETRF has announced a new round of funding for basic, translational and clinical research. Interested applicants should submit a letter of intent by June 13. The NETRF mission is to accelerate scientific discovery to help create new and more effective therapies for carcinoid, pancreatic, bronchial and other types of NETs. More.

Guthy-Jackson Charitable Foundation Participates in Unite to Cure: Fourth International Vatican Conference

Victoria Jackson, founder of the Guthy-Jackson Charitable Foundation, was honored for advancing understanding and funding for neuromyelitis optical (NMO) and related disorders at the recent Fourth International Vatican Conference. Read the Foundation’s blog about this event and current NMO awareness and research activities.

Dup15q Alliance to Co-Host Symposium

Join the Dup15q Alliance and the Angelman Syndrome Research Foundation from August 6-7 for world-class scientific, translational and clinical presentations. This symposium allows for the sharing of unpublished work, which leads to conceptual discussions with an outstanding community of researchers and clinicians, and helps to accelerate therapeutic opportunities for both disorders. Register now.

Cure SMA to Host Annual Conference June 14-17 in Dallas

Since 1988, Cure SMA has hosted an annual conference for patients, caregivers and healthcare professionals. This year’s event will take place in June in Dallas. More. Cure SMA is also conducting a survey of pediatricians to assess baseline awareness of spinal muscular atrophy. The 2018 Physician Survey can be accessed here.

National PKU Alliance Presents Poster at GMDI Meeting

Genetic Metabolic Dietitians International held their biannual meeting in Orlando Florida in April 2018 during which the National PKU Alliance represented by executive director Christine Brown and PKU Registry coordinator Eileen Blakely presented their poster, "Post Launch Observations - PKU Patient Registry. " More.

The MDS Foundation, Inc. Plans Patient/Caregiver Forum

Join the MDS Foundation on June 9th for their Patient & Family/Caregiver Forum! Whether you are a newly diagnosed patient, a long-term survivor, or a caregiver, this event will give you the opportunity to learn from experts about treatment therapies and strategies for patients and caregivers with MDS. More.

The Hydrocephalus Association to Host Conference

The Hydrocephalus Association is holding their National Conference on Hydrocephalus from June 28-30, in Orange County, CA. Join in person or via live stream to hear from world-renowned medical professionals and to connect with others living with hydrocephalus. More.

Join colleagues and a diverse panel of speakers for a CME/CEU-certified symposium for healthcare professionals treating patients with hydrocephalus. Participants can attend in person or via live stream. More.

The LAM Foundation Invites Participation in Worldwide LAM Awareness Month

June has been designated Worldwide LAM Awareness Month (WWLAM) by the Worldwide LAM Patient Coalition and The LAM Foundation. The LAM Foundation urges you to take part in Worldwide LAM Awareness Month by using #WWLAM on social media. Check out other ways to get involved here.

Join The Organic Acidemia Association at the FOD/OAA International Metabolic Conference

Join us at the FOD/OAA International Metabolic Conference July 6-7th, 2018 in Bloomington, MN! The focus for this conference is for families to learn more about the medical management, nutrition and the social needs of caring for yourself or a child with a chronic disorder, specifically those with rare metabolic disorders. More.

PRISMS, Inc., will Host 10th International Smith-Magenis Syndrome Conference

PRISMS is hosting their 10th International Smith-Magenis Syndrome Conference in Pittsburgh, PA this July 19-21, 2018. They will be celebrating 25 years of serving the SMS community as they host this multi-day educational event with more than 40 sessions led by experts from around the world. More.

The Amyloidosis Foundation Celebrates 15 Years of Funding Research

The Amyloidosis Foundation is celebrating 15 years of funding research for a cure, and is thankful to donors, patients and their families, and corporate sponsors who have made these efforts possible. The Foundation also recognizes its staff, board members and advisors for their leadership in these endeavors. More.

CMTC-OVM US to Host Conference in Chicago

The Global CMTC-OVM US Organization will be hosting their annual conference in Chicago this year, on July 21, 2018. The general session includes informative presentations and free clinical evaluations by the attending physician(s); as well as, a follow-up consultation with our child development specialist or registered nurse. More.

The Ehlers-Danlos Society to Host International Conference in Belgium

Clinicians and researchers are invited to an international conference to take place in Ghent, Belgium, Sept. 26-29 to discuss the molecular, pathogenic, clinical and management aspects of all types of Ehlers-Danlos syndromes. More.

New York Academy of Sciences to Present Ross Prize in Molecular Medicine to Huda Zoghbi, MD

Huda Zoghbi, MD, will receive the New York Academy of Sciences Ross Prize in Molecular Medicine for 2018 at the Academy’s upcoming event on June 5. More.


On May 17th, the National Organization of Rare Disorders (NORD) hosted its 2018 Rare Impact Awards in Washington, DC. At the event, NORD not only recognized efforts made to help the 30 million Americans affected by rare diseases, but the leading independent nonprofit organization also celebrated the 35th anniversaries of both its inception and the Orphan Drug Act. Photos are below:

NORD Rare Impact Awards
NORD Rare Impact Awards
Related Videos
How Gene and Cell Therapy Is Developing in Dermatology
Joyce Teng, MD, PhD, discusses how therapeutic advances in fields like epidermolysis bullosa should progress treatment discourse in other rare dermatoses.
The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD
Comparing New Therapies for Dystrophic Epidermolysis Bullosa
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
Dunia Hatabah, MD | Image Credit: HCPLive
Ricky Safer: What Clinicians Need to Know About PSC
Ryan T. Fischer, MD: Long-Term Odevixibat Benefit for Alagille Syndrome
Saeed Mohammad, MD: IBAT Inhibitors for Cholestatic Disease
Mercedes Martinez, MD: Treatment Strategies for Autoimmune Hepatitis
© 2024 MJH Life Sciences

All rights reserved.